$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The correct way to take and dose adjustment of Pitobrutinib
2026-02-01 22:25:32
Check Details
What happens if I stop taking lenvatinib? Will any adverse reactions occur or affect the therapeutic effect when stopping the medication?
2026-02-01 22:25:32
Check Details
How effective is Fezonaitan? How effective is it in clinical use?
2026-02-01 22:25:32
Check Details
How long does it take for Besudil to take effect? How long does it take for patients to see results after using this drug?
2026-02-01 22:25:32
Check Details
What is the function of Brivaracetam? How does it help relieve or treat a patient's condition?
2026-02-01 22:25:32
Check Details
What is the price and effectiveness of obeticholic acid? Do patients think the price is consistent with the effectiveness of the treatment?
2026-02-01 22:25:32
Check Details
What is the medical insurance reimbursement price of neratinib? Can some of the expenses be reimbursed through medical insurance?
2026-02-01 22:25:32
Check Details
How much does one month of treatment with tucatinib cost? Long-term cost analysis
2026-02-01 22:25:32
Check Details
Is Apelvis effective in patients with breast cancer bone metastases? Therapeutic effects and clinical manifestations
2026-02-01 22:25:32
Check Details
What are the common side effects of selumetinib? How to alleviate adverse reactions
2026-02-01 22:25:32
Check Details
What are the main functions and effects of cabozantinib? Which cancer types are suitable for
2026-02-01 22:25:32
Check Details
What are the functions and effects of enzalutamide? How does it help treat prostate cancer?
2026-02-01 22:25:32
Check Details
1
2
...
1429
1430
1431
1432
1433
1434
1435
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
2
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
3
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
4
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
5
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
6
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
7
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
8
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
9
Filgotinib: Mechanism of Action and Clinical Applications Explained
10
Lapatinib: Proper Administration Guide and Key Precautions
11
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
12
Cemiplimab Storage and Handling Guide